ASCH

Integrating Hypnotherapy and Brainspotting (NTSCH)
2026-05-27 | Virtual
Organization: North Texas Society of Clinical Hypnosis
Website: www.northtexashypnosis.org
Event Title: Integrating Hypnotherapy and Brainspotting
Agenda: Agenda
Dates: 05/27/2026
Location: Virtual
CE: 1.5
Contact : Tracy Watson, tracypaytonwatson@gmail.com
Description: This training introduces clinicians to the integration of hypnotherapy and Brainspotting as complementary, neurobiologically informed approaches for addressing trauma, emotional dysregulation, and entrenched behavioral patterns. Participants will receive a brief review of Brainspotting, including its theoretical foundations, the use of eye position to access subcortical processing, and the role of relational and dual attunement in facilitating regulation and resolution. The workshop explores how hypnotic induction, focused attention, ego-strengthening interventions, and therapeutic suggestion can enhance stabilization, deepen processing, and support integration within a Brainspotting framework. Through a structured case study, participants examine clinical sequencing, pacing, contraindications, ethical considerations, and scope-of-practice issues relevant to interdisciplinary practice. Designed for clinicians seeking to expand trauma-informed competencies, this training emphasizes client safety, autonomy, and responsible integration of brain-based and experiential methods.
Learning Objectives: At the conclusion of the training each participant will be able to:

Summarize the core principles and neurobiological foundations of Brainspotting.

Describe at least three clinical applications of hypnotherapy that complement Brainspotting.

Identify at least three appropriate stabilization and pacing strategies when integrating both modalities.

Recognize contraindications, ethical considerations, and scope-of-practice factors relevant to interdisciplinary practice.

Apply integration concepts to a case example to support trauma-informed clinical decision-making.

Speaker info: Teresa Jackson, PhD Resume-02-2026-Jackson-T

Clinical Hypnosis Level 1 (Lemke Counseling & Consulting)
2026-06-09 - 2026-06-11 | Virtual
Organization: Lemke Counseling & Consulting
Website: https://www.wendylemke-psy.com/general-4
Event Title: Level 1 Clinical Hypnosis
Dates: June 9-11th, 2026
Location: Virtual
CE: 20.5
Agenda: Content_Schedule_for_Level_1_Hypnosis_2024
Contact : wendylemkelp@gmail.com
Description: Even though we all have the capacity for trance, we often are not consciously aware of utilizing this capacity in a constructive manner. The Fundamental Level 1 training will assist you in facilitating constructive trances, making the most out of those states with effective and timely therapeutic suggestions. It will also help you recognize destructive spontaneous trance states, destructive self-suggestions, and provide ways to ground and reorient. Taught by trauma-informed faculty, this course will include topics/skills on hypnotic phenomena, hypnotic language, elicitations, deepening, reorienting, utilization, formulating suggestions, along with opportunities for supervised practice.
Speaker info: Wendy Lemke

Advanced Workshop: Integrating Clinical Hypnosis and EMDR
2026-06-20
Integrating Clinical Hypnosis and EMDR (ASCH Virtual Advanced Workshop)
Date and Time (Eastern): June 20th – 11AM ET – 6PM ET
Breaks will be from 12:30-12:45PM ET; 2:15-2:45PM ET; and 4:15-4:30PM ET
REGISTER HERE –https://portal.asch.net/integratedEvents/home/ASCH-ADVANCED-LEVEL-WORKSHOP-INTEGRATING-CLINICAL-HYPNOSIS-AND-EMDR
Location: Virtual / Zoom
CE Hours: 6.5 hours
This one-day workshop examines practical strategies for integrating clinical hypnosis across all eight phases of EMDR therapy. Participants will be introduced to a variety of hypnotic interventions, with clear guidance on when and how to apply them within the EMDR framework. Case examples will demonstrate real-world integration and clinical decision-making.
By the end of this workshop, participants will be able to:

List benefits of integrating clinical hypnosis with EMDR Therapy.
Describe how clinical hypnosis and EMDR can be effectively integrated in practice.
Identify clinical hypnosis techniques that can be applied in each of EMDR’s 8 Phases.
Create a treatment plan incorporating EMDR and clinical hypnosis for a hypothetical client.
Identify ethical considerations in integrating clinical hypnosis and EMDR therapy.

Speaker/Instructor : Brittany Meredith, Registered Psychologist (AB)
Brittany provides counselling to individuals impacted by trauma, complex trauma, grief, anxiety, body-focused repetitive behaviours, and pain in her private practice. In addition to counselling, Brittany is an EMDR Consultant and training coach, ASCH Certified in Clinical Hypnosis, and provides supervision to Registered Provisional Psychologists, and counselling students. Having practiced clinical hypnosis since 2013, and EMDR since 2016, Brittany is excited to share about integrating these powerful modalities. In addition to counselling, Brittany is the primary handler for Lions Foundation of Canada Facility Support Program Dog Guide, Indus (pictured here), who works in Power Psychology’s offices. Brittany spent many years on the CFCH-AS board, including as President, has sat on the EMDR Canada Board, and is currently on the Clinical Hypnosis Education and Training Committee with ASCH.
Registration Fees: Member $175; Nonmember: $235; Grad $140; Intern/resident $140
Registration Closing Date: June 13, 2026
Cancellations: Cancellations must be made in writing to info@asch.net . No cancellations will be taken by phone. Cancellations made by June 6th, 2026 will receive a full refund minus a $50 administrative fee. No refunds will be made for cancellations made after that date unless the seat can be filled by a waitlisted person.
Workshop CME & ASCH Continuing Education (CE) Credits
This program has been approved by the American Society of Clinical Hypnosis Standards of Training Committee to be used toward Membership and Certification requirements.
The American Society of Clinical Hypnosis-Education and Research Foundation (ASCH-ERF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Clinical Hypnosis-Education and Research Foundation (ASCH-ERF) designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program is Approved by the National Association of Social Workers (886386995-7390) for 6.50 continuing education contact hours.
This course is approved by the American Society of Clinical Hypnosis and as such is an approved continuing education course per Florida’s AC-Rule 64B-4-6002 American Society of Clinical Hypnosis-ERF is designated as an Approved PACE Program Provider.
The American Society of Clinical Hypnosis Education & Research Foundation Nationally Approved PACE Program Provider for FAGD/MAGD credit. Approval does not imply acceptance by any regulatory authority or AGD endorsement. 10/1/2024 to 9/30/2027. Provider ID#217022
American Group Psychotherapy Association (AGPA) is approved by the American Psychological Association to sponsor continuing education for psychologists and the American Society of Clinical Hypnosis (ASCH). American Group Psychotherapy Association (AGPA) is approved by the American Psychological Association to sponsor continuing education for psychologists.

The Unique Suitability of Hypnosis for Resolving Trauma and Managing Dissociation (NTSCH)
2026-06-24 | Virtual
Organization: North Texas Society of Clinical Hypnosis
Website: https://www.northtexashypnosis.org/
Title: The Unique Suitability of Hypnosis for Resolving Trauma and Managing Dissociation
Agenda: June_Agenda
Dates: 06/24/2026
Location: Virtual
CE: 1.5
Contact : Tracy Payton Watson, LPC tracypaytonwatson@gmail.com
Description: It is well-established in the research literature that psychological traumatization and dissociation are distinctive states with characteristic psychological and psychophysiological features. Similarly, a growing body of research confirms that hypnosis has identifiable psychophysiological attributes, and that hypnosis and dissociation are related. Consequently, hypnotically informed intervention approaches are uniquely suited to foster constructive, enduring state change in chronically traumatized and dissociative individuals. This workshop will focus on practical applications of these principles by identifying various components of trauma- and dissociation-relevant treatment that can be facilitated by using hypnosis for: relationship building through strengthening rapport; distress reduction; expanding coping skills through imagery rehearsal; increasing self-esteem by challenging convictions that sustain negative self-image; reducing disruptive levels of hyperarousal during trauma processing; and managing and mastering dissociative states by learning to modulate their intensity. Brief illustrative case examples will be included. Attendees will be encouraged to adopt the hypnotic strategies presented in this session as jumping-off points for tailoring them to the intersectional needs, perspectives, personal and family histories, and cultural backgrounds of each individual client.
Learning Objectives: By the end of the session, participants will be able to adapt and demonstrate at least two of the six hypnotic strategies presented by outlining how they would implement them with a current or sample client and achieve a score of 80% or higher on a post-training competency checklist or role-play evaluation.
Speaker info: Steven N Gold, PhD Gold_bio_12-2025

Curious Minds: Psychedelic Therapy Meets Clinical Hypnosis (NTSCH)
2026-09-11 - 2026-09-12 | Hybrid
Organization: North Texas Society of Clinical Hypnosis
Website: https://northtexashypnosis.org/
Event Title: Curious Minds: Psychedelic Therapy Meets Clinical Hypnosis
Advanced Workshop
Agenda: Agenda
Dates: 09/11/2026 & 09/12/2026
Location: Hybrid
CE: 16
Contact : Tracy Payton Watson, LPC tracypaytonwatson@gmail.com
Description: This workshop is intended for health professionals who want to learn about the emerging field of psychedelic-assisted therapy (PAT) and how hypnosis can support individuals in this context. Participants will gain an understanding of the primary agents used in PAT, their neurobiological effects, therapeutic indications, and a typical protocol for preparation, dosing, and integration. The session will address ethical and legal considerations, clinical risks, and principles of harm reduction.
A central focus is the application of clinical hypnosis to assist clients during the preparation and integration phases of psychedelic experiences. Through a blend of presentations, group discussions, and experiential exercises, attendees will explore hypnotic principles and interventions that clarify intention, facilitate navigation of expanded states, and promote integration of insights. The workshop will highlight how hypnosis can evoke transformative and “mystical” experiences and support emotional and behavioral change, all grounded in the latest neuroscience and clinical research. Join us to deepen your understanding of this emerging field and expand your therapeutic skills for working with clients interested in or undergoing psychedelic-assisted therapy.
Learning Objectives:
1. Advanced Workshop Introduction and Overview: Exploring the intersection between psychedelic assisted therapy and clinical hypnosis
At the conclusion of this session, the participant will be able to: Describe two similarities between hypnotic and psychedelic states
2. Brief history of psychedelic use
At the conclusion of this session, the participant will be able to:

Describe the historical development of psychedelic therapies from indigenous traditions to contemporary clinical research
Identify two major milestones in the modern resurgence of psychedelic research
Identify two potential clinical applications of combining hypnosis with psychedelic therapy

3. Introduction to psychedelics
At the conclusion of this session, the participant will be able to:

Identify four commonly studied psychedelic or psychedelic-adjacent compounds used in therapeutic settings
Describe at least one therapeutic mechanism associated with one compound discussed

4. Psychedelics and clinical hypnosis: Neurobiology and neuroplasticity
At the conclusion of this session, the participant will be able to:

Describe two neurobiological mechanisms associated with psychedelic states
Explain how neuroplasticity contributes to therapeutic change in psychedelic-assisted therapy
Identify two similarities between hypnotic and psychedelic shifts in attention and perception

Psychedelics and therapeutic applications

At the conclusion of this session, the participant will be able to:

Identify four mental health conditions currently studied in psychedelic-assisted therapy
Describe how hypnosis complements psychedelic-assisted treatment for at least one of the conditions discussed

Psychedelics, clinical hypnosis, and trauma therapy

At the conclusion of this session, the participant will be able to:

Describe two potential benefits of psychedelic-assisted therapy for trauma treatment
Identify one way clinical hypnosis can support trauma processing before or after a psychedelic session

Mystical experiences

At the conclusion of this session, the participant will be able to:

Describe mystical experience as described in psychedelic research literature
Identify two therapeutic implications of mystical-type experiences

Mystical Experience Experiential and wrap up

At the conclusion of this session, the participant will be able to:

Observe the use of hypnotic techniques to facilitate altered states of awareness

Common therapeutic models in psychedelic assisted therapy

At the conclusion of this session, the participant will be able to:

Identify three therapeutic models used in psychedelic-assisted therapy
Describe how one of these models aligns with hypnotherapeutic approaches

Overview – Stages of psychedelic assisted therapy

At the conclusion of this session, the participant will be able to:

List four stages of psychedelic-assisted therapy
Describe the clinical purpose of each stage

Hypnotic techniques for preparation and session facilitation

At the conclusion of this session, the participant will be able to:

Describe two strategies for psychological preparation prior to psychedelic sessions
Identify one hypnotic technique to facilitate/support safety
Describe and apply two hypnotic strategies for affect regulation

Hypnotic techniques for integration

At the conclusion of this session, the participant will be able to:

Describe two goals of integration following psychedelic experiences
Identify two hypnotic strategies to support post-session meaning-making and integration

Ethics and Clinical Considerations

At the conclusion of this session, the participant will be able to:

Identify two ethical considerations relevant to psychedelic-assisted therapy
Identify two safety considerations for psychedelic-assisted therapy
Have any questions about the workshop answered

Speaker info:
Ciara Christensen, PhD – Ciara_C_2025_CV
